EB
Enox Biopharma Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by David Itamar, was filed 05 Nov 2010.
Enox Biopharma Inc: what insiders have been doing
Enox Biopharma Inc is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Enox Biopharma Inc. The previous disclosure was published on 5 November 2010.
Our records for Enox Biopharma Inc go back to 2009, with 5 purchases and no sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€174,078
5 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 5 November 2010
Declarations5 total
- 201,122 shares@ US$0.30Common StockSEC:0001165527-10-000824:0Canonical exit: 2 Feb 2011 (T+90)
- 201,122 shares@ US$0.30Common StockSEC:0001165527-10-000600:0Canonical exit: 13 Oct 2010 (T+90)
- 25,000 shares@ US$2.00Common StockSEC:0001165527-10-000600:1Canonical exit: 10 Nov 2010 (T+90)
- 25,000 shares@ US$2.00Common StockSEC:0001165527-10-000599:0Canonical exit: 10 Nov 2010 (T+90)
- 80,846 shares@ US$0.1237Common StockSEC:0001165527-09-000824:0Canonical exit: 31 Jan 2010 (T+90)
5 of 5 declarations
About Enox Biopharma Inc
Enox Biopharma Inc is a company focused on developing biopharmaceutical solutions. It is listed on the XNAS market.
